Aristotle Capital Boston’s Novanta NOVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $19.6M | Sell |
165,939
-10,737
| -6% | -$1.41M | 1.22% | 24 |
|
|
2025
Q4 | $21M | Buy |
176,676
+27,791
| +19% | +$3.16M | 1.15% | 28 |
|
|
2025
Q3 | $14.9M | Buy |
148,885
+26,229
| +21% | +$3.12M | 0.77% | 58 |
|
|
2025
Q2 | $15.8M | Sell |
122,656
-6,859
| -5% | -$835K | 0.81% | 46 |
|
|
2025
Q1 | $16.6M | Sell |
129,515
-22,140
| -15% | -$3.18M | 0.83% | 47 |
|
|
2024
Q4 | $23.2M | Sell |
151,655
-18,299
| -11% | -$3.1M | 0.86% | 47 |
|
|
2024
Q3 | $30.4M | Buy |
169,954
+1,219
| +0.7% | +$212K | 1.01% | 40 |
|
|
2024
Q2 | $27.5M | Sell |
168,735
-3,829
| -2% | -$621K | 0.93% | 42 |
|
|
2024
Q1 | $30.2M | Sell |
172,564
-1,067
| -0.6% | -$175K | 0.92% | 43 |
|
|
2023
Q4 | $29.2M | Buy |
173,631
+2,475
| +1% | +$361K | 0.89% | 46 |
|
|
2023
Q3 | $24.6M | Sell |
171,156
-9,755
| -5% | -$1.59M | 0.79% | 52 |
|
|
2023
Q2 | $33.3M | Buy |
180,911
+2,204
| +1% | +$361K | 1% | 39 |
|
|
2023
Q1 | $28.4M | Buy |
178,707
+1,668
| +0.9% | +$256K | 0.88% | 47 |
|
|
2022
Q4 | $24.1M | Sell |
177,039
-3,400
| -2% | -$476K | 0.76% | 56 |
|
|
2022
Q3 | $20.9M | Sell |
180,439
-8,670
| -5% | -$1.18M | 0.71% | 58 |
|
|
2022
Q2 | $22.9M | Buy |
189,109
+9,078
| +5% | +$1.14M | 0.68% | 59 |
|
|
2022
Q1 | $25.6M | Sell |
180,031
-6,734
| -4% | -$956K | 0.65% | 69 |
|
|
2021
Q4 | $32.9M | Sell |
186,765
-1,803
| -1% | -$301K | 0.77% | 54 |
|
|
2021
Q3 | $29.1M | Sell |
188,568
-29,920
| -14% | -$4.35M | 0.68% | 65 |
|
|
2021
Q2 | $29.4M | Sell |
218,488
-68,134
| -24% | -$9.17M | 0.67% | 64 |
|
|
2021
Q1 | $37.8M | Sell |
286,622
-6,102
| -2% | -$802K | 0.84% | 45 |
|
|
2020
Q4 | $34.6M | Sell |
292,724
-84,295
| -22% | -$9.83M | 0.82% | 43 |
|
|
2020
Q3 | $39.7M | Buy |
377,019
+4,674
| +1% | +$494K | 1.15% | 24 |
|
|
2020
Q2 | $39.8M | Buy |
372,345
+41,002
| +12% | +$3.81M | 1.21% | 28 |
|
|
2020
Q1 | $26.5M | Sell |
331,343
-54,323
| -14% | -$4.85M | 1.13% | 29 |
|
|
2019
Q4 | $34.1M | Buy |
385,666
+23,931
| +7% | +$2.06M | 0.94% | 39 |
|
|
2019
Q3 | $29.6M | Buy |
361,735
+11,200
| +3% | +$910K | 0.87% | 47 |
|
|
2019
Q2 | $33.1M | Buy |
350,535
+12,197
| +4% | +$1.04M | 1.03% | 33 |
|
|
2019
Q1 | $28.7M | Buy |
338,338
+134,650
| +66% | +$10.1M | 0.96% | 40 |
|
|
2018
Q4 | $12.8M | Buy |
203,688
+26,141
| +15% | +$1.69M | 1.05% | 37 |
|
|
2018
Q3 | $12.1M | Sell |
177,547
-30,085
| -14% | -$2.11M | 0.89% | 53 |
|
|
2018
Q2 | $12.9M | Sell |
207,632
-9,243
| -4% | -$565K | 1.03% | 43 |
|
|
2018
Q1 | $11.3M | Buy |
216,875
+51,646
| +31% | +$2.83M | 0.53% | 80 |
|
|
2017
Q4 | $8.26M | Sell |
165,229
-106,249
| -39% | -$5.18M | 0.6% | 77 |
|
|
2017
Q3 | $11.8M | Sell |
271,478
-85,046
| -24% | -$3.31M | 1.06% | 31 |
|
|
2017
Q2 | $12.8M | Sell |
356,524
-80,136
| -18% | -$2.54M | 1.43% | 18 |
|
|
2017
Q1 | $11.6M | Buy |
436,660
+50,311
| +13% | +$1.23M | 1.55% | 15 |
|
|
2016
Q4 | $8.11M | Sell |
386,349
-10,538
| -3% | -$201K | 1.11% | 31 |
|
|
2016
Q3 | $6.89M | Buy |
396,887
+15,139
| +4% | +$249K | 1.23% | 29 |
|
|
2016
Q2 | $5.78M | Buy |
+381,748
| New | +$5.87M | 1.12% | 33 |
|
Other funds holding NOVT
VPM
VCM
CCA
WA
GCM
Aristotle Capital Boston's NOVT Position: Q1 2026 in Review
Aristotle Capital Boston reduced its Novanta (NOVT) stake by 6.1% in Q1 2026, selling an estimated $1.41M and leaving 165,939 shares worth $19.6M. The position accounts for 1.22% of the portfolio, ranked #24.
Aristotle Capital Boston first reported a position in NOVT in Q2 2016 and has held it in 40 quarters since. The position peaked at $39.8M in Q2 2020. 329 funds tracked by Wall St. Rank hold NOVT as of Q1 2026.
- Aristotle Capital Boston held 165,939 shares of Novanta worth $19.6M as of Q1 2026.
- Aristotle Capital Boston sold 10,737 Novanta shares in Q1 2026, an estimated $1.41M.
- Novanta made up 1.22% of Aristotle Capital Boston's portfolio in Q1 2026, its #24 holding.
- Aristotle Capital Boston first reported a position in Novanta in Q2 2016 and has held it in 40 quarters since.
- Aristotle Capital Boston's Novanta position peaked at $39.8M in Q2 2020.
- 329 funds tracked by Wall St. Rank held Novanta as of Q1 2026.
Based on Aristotle Capital Boston's 13F filing for Q1 2026, filed 15 May 2026.